You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites.
Cancel Ok

CARDIOVASCULAR


IDEAS COME FROM THE HEART

Arena Pharmaceuticals is expanding our capabilities to study cardiovascular conditions like acute heart failure and coronary microvascular obstruction.
  • ABOUT ACUTE HEART FAILURE

    Acute heart failure (AHF) is a rapid onset of new or worsening symptoms of heart failure. This means your heart can’t pump enough blood. It is a potentially life-threatening condition requiring hospitalization and emergency treatment.

  • ABOUT CORONARY MICROVASCULAR OBSTRUCTION

    Coronary microvascular obstruction (cMVO) is a condition characterized by the failure to achieve full myocardial or microcirculatory reperfusion despite resolution of epicardial coronary occlusion and flow by a percutaneous coronary intervention (PCI). PCI results in activation of platelets and release of serotonin (5-HT), which mediates platelet aggregation and vasoconstriction.